VITRAKVI (LAROTRECTINIB)

**Product type:** Human Prescription Drug

**Active ingredient:** LAROTRECTINIB

**Strength:** 25 mg/1

**Dosage form:** Capsule

**Route:** Oral

**Labeler:** Loxo Oncology, Inc.

**Marketing category:** NDA (NDA210861)

**Pharmacologic class:** Kinase Inhibitor [EPC], Tropomyosin Receptor Kinases Inhibitors [MoA]